Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ACURA PHARMACEUTICALS, INC (ACUR)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues   [+]1.63.62.70.43.04.58.60.8
            Revenue growth  -56.2%34.4%548.0%-86.2%-33.6%-48.0%1043.4%510.6%
Cost of goods sold  0.00.00.00.00.10.50.70.2
Gross profit  1.63.62.70.42.84.07.90.5
            Gross margin  100.0%100.0%100.0%100.0%95.7%89.9%92.4%69.8%
Selling, general and administrative  1.32.51.92.64.36.59.07.9
Research and development  1.51.81.51.83.74.02.64.6
Other operating expenses       0.00.30.2
EBITDA   [+]-1.1-0.6-0.5-3.6-4.9-6.2-3.7-11.9
            EBITDA margin  -73.0%-17.7%-17.0%-886.6%-166.3%-139.2%-42.7%-1587.9%
Depreciation  0.00.10.10.10.10.10.10.1
EBITA  -1.2-0.7-0.5-3.7-5.0-6.4-3.8-12.0
            EBITA margin  -76.0%-19.3%-19.5%-904.4%-169.2%-142.2%-44.2%-1603.7%
Amortization of intangibles  0.00.10.20.20.20.20.20.2
EBIT   [+]-1.2-0.8-0.7-3.9-5.2-6.6-4.0-12.2
            EBIT margin  -77.7%-21.2%-27.3%-954.9%-176.2%-146.9%-46.6%-1624.4%
Interest expense, net   [+]0.20.50.40.20.60.81.01.0
Other income (expense), net   [+]0.5 -2.60.30.00.00.00.0
Pre-tax income  -0.9-1.2-3.8-3.8-5.8-7.4-5.0-13.2
Income taxes  0.00.00.00.0-0.10.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%2.3%0.0%0.0%0.0%
Net income  -0.9-1.2-3.8-3.8-5.7-7.4-5.0-13.2
            Net margin  -56.2%-33.8%-142.0%-937.1%-191.6%-165.5%-58.1%-1758.9%
   
Basic EPS   [+]($0.02)($0.04)($0.14)($0.18)($0.36)($0.62)($0.46)($1.35)
Diluted EPS   [+]($0.02)($0.04)($0.14)($0.18)($0.36)($0.62)($0.46)($1.35)
   
Shares outstanding (basic)   [+]56.832.326.721.115.911.910.89.8
Shares outstanding (diluted)   [+]56.832.326.721.115.911.910.89.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy